Cargando…
Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery
The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery un...
Autores principales: | Ferrandis, Raquel, Llau, Juan V., Mugarra, Ana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805815/ https://www.ncbi.nlm.nih.gov/pubmed/20436853 http://dx.doi.org/10.2174/157340309788166688 |
Ejemplares similares
-
Prevention of the renarrowing of coronary arteries using drug-eluting stents in the perioperative period: an update
por: Llau, Juan V, et al.
Publicado: (2010) -
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey
por: Ferrandis, Raquel, et al.
Publicado: (2021) -
Factors Associated with Inadequate Management of Antiplatelet Agents
in Perioperative Period of Non-Cardiac Surgeries
por: Borges, Juliana Maria Dantas Mendonça, et al.
Publicado: (2018) -
Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012) -
Antiplatelet agents in perioperative noncardiac surgeries: to maintain or to suspend?
por: Borges, Juliana Maria Dantas Mendonça, et al.
Publicado: (2018)